Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Pilot Study of Biomarkers for Spinal Muscular Atrophy (BforSMA)

This study has been completed.
Sponsor:
Collaborator:
The Spinal Muscular Atrophy Foundation
Information provided by:
New England Research Institutes
ClinicalTrials.gov Identifier:
NCT00756821
First received: September 18, 2008
Last updated: October 23, 2012
Last verified: October 2012